Xencor | SCHULD



Debt Veränderung Datum
AbbVie USD 69.89B 2.74B 2025-03
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Amgen USD 56.2B 1.18B 2025-06
Arrowhead Research USD 388.24M 21.18M 2025-03
AstraZeneca USD 32.84B 1.19B 2025-06
Biogen USD 6.59B 296.8M 2025-06
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Cytokinetics USD 658.13M 1.01M 2025-03
GlaxoSmithKline GBP 17.35B 1.08B 2025-06
J&J USD 52.25B 15.62B 2025-03
MacroGenics USD 0 0 2024-12
Merck USD 34.84B 2.27B 2025-03
Novartis USD 31.27B 12M 2025-03
Pfizer USD 60.93B 1.18B 2025-06
Regeneron Pharmaceuticals USD 2.71B 300K 2025-06
Roche Holding CHF 34.44B 5.23B 2024-06
Xencor USD 67.93M 86.45M 2025-06


Xencor SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.